SCHEMBL6573773

SCHEMBL6573773

c1ccc(NCCN(c2ccccc2)P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.39
HRH3 Q9Y5N1 1/20 0.32
KCNH2 Q12809 1/20 0.31
DRD4 P21917 2/20 0.31
MTNR1A P48039 1/20 0.30
MTNR1B P49286 1/20 0.30
TAAR1 Q96RJ0 1/20 0.30
CA12 O43570 1/20 0.30
CA2 P00918 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3305686 0.81 CYP3A4 (0.38) ALDH1A1MAPTL3MBTL1KCNH2
SCHEMBL28986677 0.74 ALDH1A1 (0.54) ALDH1A1MAPTL3MBTL1HRH3KCNH2
SCHEMBL27644720 0.71 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1DRD4MTNR1A
SCHEMBL7523541 0.71 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1HRH3KCNH2
SCHEMBL11729095 0.70 TSHR (0.41) ALDH1A1MAPTL3MBTL1KCNH2
SCHEMBL171395 0.67 ALDH1A1 (0.56) ALDH1A1MAPTL3MBTL1TAAR1
SCHEMBL232188 0.67 MAPT (0.78) ALDH1A1MAPTL3MBTL1HRH3DRD4
SCHEMBL6842001 0.67 MAPT (0.45) ALDH1A1MAPTL3MBTL1
SCHEMBL7066835 0.66 ALDH1A1 (0.54) ALDH1A1MAPTL3MBTL1HRH3DRD4
SCHEMBL16755617 0.66 TDP1 (0.43) ALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1395551-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND SIMILAR DISEASES Elan Pharmaceuticals, Inc. (US) 2004-03-10 EP disclosed
WO-2002098849-A2 HYDROXY ALKYL AMINE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND SIMILAR DISEASES ELAN PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed